fermentek

 

Fermentek homepage
about
products
contact us

Resources

Salu KJ, Huang Y, Bosmans JM, Liu X, Li S, Wang L, Verbeken E, Bult H, Vrints CJ, De Scheerder IK.

Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model.

Coron Artery Dis. 2003 Dec;14(8):545-55

Division of Cardiology, University of Antwerp, Wilrijk, Belgium. koen.salu@ua.ac.be


BACKGROUND: Polymer-based, drug-eluting stents, are currently under extensive investigation in the conquest against in-stent restenosis. Concern remains, however, about potential long-term lack of biocompatibility of the polymers used in these studies. Therefore, this study aimed to evaluate in porcine coronary arteries (1) the in vivo biocompatibility of a new natural, eicosapentaenoic acid oil stent-coating and (2) the efficacy of this coating in preventing in-stent restenosis when cytochalasin D--an inhibitor of actin filament formation, that interferes with cell proliferation and migration--was added. METHODS AND RESULTS: To assess in vivo biocompatibility of the oil coating, 15 bare and 15 oil-coated stents were randomly deployed in coronary arteries of 15 pigs. No difference in tissue response, regarding inflammation or proliferation, was seen between both groups at five days or at four weeks follow-up. To evaluate the efficacy of the coating in preventing in-stent restenosis by adding a potential anti-restenotic drug, stents were dip-coated in 20 mg cytochalasin D/ml oil solution, resulting in 93 +/- 18 microg cytochalasin D/stent load (n = 3). In vitro drug release studies showed sustained release up to four weeks. Next, 11 oil-coated and 11 cytochalasin D-loaded stents were randomly implanted in coronary arteries of 11 pigs. At four weeks, a 39% decrease in neointimal hyperplasia (p < 0.05, ANCOVA, with injury as covariate) was found in cytochalasin D-loaded stents compared to oil-coated stents. CONCLUSIONS: This new natural oil stent-coating shows excellent biocompatibility to vascular tissue. Local cytochalasin D delivery from this stent-platform significantly inhibits neointimal hyperplasia in a porcine coronary model. Copyright 2003 Lippincott Williams & Wilkins

PMID: 14646676
 

back to product page

 
fermentek  

Sitemap
Home Products Hebrew About us ISO GMP/API Mad cow GMO | Sales policy Receiving RFQ OrderingContact webmaster Ask scientist Contact sales  |
Privacy About website Copyright

Products
7AAD 17AAG 17DMAG A23187, 4-Bromo A23187, Ca/ Mg salt A23187 (free acid) Actinomycin D Aflatoxin B1 Aflatoxin B2 Aflatoxin G1 Aflatoxin G2 Aflatoxin M1 Aflatoxin M2 Alamethicin Anisomycin Apicidin Aphidicolin Ascomycin Bafilomycin A1 Brefeldin A castanospermine Cerulenin Chelerythrine Chromomycin A3 Citrinin Cyclopiazonic acid Cytochalasin A Cytochalasin B Cytochalasin C Cytochalasin D Cytochalasin E Dihidrocytochalasin Deoxynivalenol FK506 Forskolin Fumagillin Fumonisin B1 Fumonisin B2 Geldanamycin Genistein Gliotoxin Hypericin HT2 toxin Ionomycin Ca K252A K252B KT5720 KT5823 Leptomycin B Mithramycin A Mitomycin C Moniliformin Mycophenolic Myriocin Nigericin Nonactin Ochratoxin A Oligomycin Oligomycin A Oligomycin B Parthenolide Patulin Paxilline Penicillic acid Penitrem A PKC412 Puromycin Puromycin AN Radicicol Rapamycin Staurosporine Sirolimus Sterigmatocystin T2 toxin Taxol Tentoxin Thapsigargin Thiolutin Triacsin Trichostatin Tunicamycin Valinomycin Verruculogen Vomitoxin Withaferin A Wortmannin Zearalenone


unique visitor counter
 
Company's eMail: 

Anti-spam measures have been taken here. Please copy this address into your eMail software. We are sorry for the inconvenience.

Mail Address:

Yatziv 25, POB 47120, Jerusalem 97800 Israel

Phone: 972 2 5853953

Fax: 972 2 5853943


 

 

 

 

My Green Corner spam safe site

ab, abh

--

ZZZ from Fermentek for sale